SCHEDULE OF INVESTMENTS (Details) - USD ($) |
Jun. 30, 2026 |
Dec. 31, 2025 |
|---|---|---|
| Equity method investment | $ 12,730,703 | $ 13,626,858 |
| Cost method investment | 1,000,000 | 1,000,000 |
| Total Investments | 13,730,703 | 14,626,858 |
| Biomimetic Innovations Limited [Member] | ||
| Equity method investment | $ 8,004,716 | $ 8,741,389 |
| Economic interest | 11.95% | 12.50% |
| ChemoMouthpiece, LLC [Member] | ||
| Equity method investment | $ 4,688,613 | $ 4,841,695 |
| Economic interest | 6.59% | 6.59% |
| SI Healthcare Technologies LLC [Member] | ||
| Equity method investment | $ 37,374 | $ 43,774 |
| Economic interest | 50.00% | 50.00% |
| Direct Dermatology Inc. [Member] | ||
| Cost method investment | $ 1,000,000 | $ 1,000,000 |
| X | ||||||||||
- Definition Equity Method Investments Economic Interest. No definition available.
|
| X | ||||||||||
- Definition This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Sum of the carrying amounts as of the balance sheet date of all investments. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Includes other investments and securities that are not at fair value as of the balance sheet date and those that are not accounted for under the equity method. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|